Biotherapeutics are still relatively new in veterinary medicine. This article reviews biologic therapy as it relates specifically to monoclonal antibodies (mAbs) and covers the only fully licensed and commercially available product, lokivetmab (Cytopoint).

Respiratory Distress Management of a small animal with an environmental lung injury—e.g., due to drowning—differs from the care given for other types of respiratory compromise. Environmental lung injury can result from several causes, including drowning or smoke exposure from enclosed-space fires. Management of patients with environmental lung injuries differs from management of patients with the …